Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(1)

deferasirox

1 trial

phase_2

city-of-hope-medical-center

1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01159067Phase 2Terminated

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+99 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Accelerated Phase Chronic Myelogenous Leukemia1 Adult Acute Lymphoblastic Leukemia in Remission1 Adult Acute Myeloid Leukemia in Remission1 Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities1 Adult Acute Myeloid Leukemia With Del(5q)1 Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)1 Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)1 Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)1

Affiliations

City of Hope Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ryotaro Nakamura

City of Hope Medical Center

10 trials

Shared therapeutic areas:

Primary MyelofibrosisExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+84 more

Worked with same sponsors:

City of Hope Medical Center

Similarity Score26%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

11 trials

Shared therapeutic areas:

Recurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+77 more

Similarity Score24%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

12 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRefractory Chronic Lymphocytic Leukemia+72 more

Similarity Score22%

Shaji Kumar

Mayo Clinic

10 trials

Shared therapeutic areas:

Stage III Multiple MyelomaRefractory Chronic Lymphocytic LeukemiaStage I Multiple Myeloma+18 more

Similarity Score6%

Roger Strair, MD, PhD

Rutgers Cancer Institute of New Jersey

10 trials

Shared therapeutic areas:

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+3 more

Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Stage IV Breast CancerNoncontiguous Stage II Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+2 more

Similarity Score1%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

13 trials

Shared therapeutic areas:

Stage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more

Similarity Score1%

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicPrimary MyelofibrosisRecurrent Adult Acute Myeloid Leukemia

Similarity Score1%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma

Similarity Score1%

Tapan M Kadia

M.D. Anderson Cancer Center

13 trials

Shared therapeutic areas:

Secondary Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia in RemissionPrimary Myelofibrosis

Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01159067Phase 2PrincipalInvestigator

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+99 more

Terminated

All 1 trials loaded